Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal muscle refers to the layers of smooth muscle cells that form the muscular walls of the intestines and mediate contraction and relaxation to propel and mix intestinal contents. Its major cellular subtypes are the circular and longitudinal smooth muscle layers, innervated by the enteric nervous system and regulated by neurotransmitters (like acetylcholine via muscarinic receptors), hormones, and local factors. Intestinal smooth muscle participates in peristalsis and segmentation, enabling digestive motility. While not a drug target itself, numerous receptors and ion channels expressed on these cells constitute well-established therapeutic targets for various gastrointestinal disorders, mainly focusing on the muscarinic acetylcholine receptors ( predominantly M2 and M3), calcium channels, and others[1][3][4][5][6][8]. Additional clarification: "Intestinal muscle" is not the name of a single gene, protein, receptor, or enzyme. Instead, it is a collective anatomical term for a cell type, so it does not conform to the conventions for canonical molecular targets. Therapeutic targeting occurs at the level of specific receptors or ion channels present on intestinal smooth muscle cells (e.g., muscarinic acetylcholine receptor M3, L-type calcium channel), not the "intestinal muscle" as a whole. Therefore, this is not a canonical molecular target, and the query may be too generic or imprecise for molecular targeting workflows[1][3][6][8].
Modulation of muscarinic acetylcholine receptors (primarily M2 and M3 subtypes); Inhibition/activation of voltage-gated calcium channels; cAMP/cGMP-mediated relaxation or contraction pathways
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal smooth muscle cell.